Medtech & Pharma Platform Association Competitors

The American Medical Association (AMA) is the largest and most influential organization representing the voices of hundreds of thousands of physicians, residents and medical students across the United States. Founded in 1847, the AMA works to advance the interests of physicians and patients by advocating for policies that improve access to quality care, strengthen the patient-physician relationship, promote physician autonomy and wellbeing, advance science and technology, and uphold the high medical ethics of the profession. The AMA’s mission is to promote the art and science of medicine and the betterment of public health. For more information, visit ama-assn.org. For commenting policies, see our Code of Conduct: http://bit.ly/1aEMHr2

We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments. PhRMA is committed to working with stakeholders in Washington, across the country and around the world to: 🔹Expand patient access to safe and effective medicines through a free market, without price controls 🔹Protect strong intellectual property incentives 🔹Promote transparent, effective regulation and a free flow of information to patients We’re building a policy environment where science can thrive, patients can benefit and cures can exist.

BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org